Chiranjeevi Padala

406 total citations
23 papers, 292 citations indexed

About

Chiranjeevi Padala is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chiranjeevi Padala has authored 23 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Chiranjeevi Padala's work include Protease and Inhibitor Mechanisms (4 papers), Bone Tissue Engineering Materials (3 papers) and Dental Implant Techniques and Outcomes (3 papers). Chiranjeevi Padala is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Bone Tissue Engineering Materials (3 papers) and Dental Implant Techniques and Outcomes (3 papers). Chiranjeevi Padala collaborates with scholars based in India, Spain and France. Chiranjeevi Padala's co-authors include Bramanandam Manavathi, Srinath Palakurthy, K. Venugopal Reddy, P. Abdul Azeem, R. Prasada Rao, Vishnupriya Satti, Made Ratna Saraswati, Vasudevarao Penugurti, Kishore Kumar and S. Vishnupriya and has published in prestigious journals such as PLoS ONE, Scientific Reports and Polymer.

In The Last Decade

Chiranjeevi Padala

23 papers receiving 287 citations

Peers

Countries citing papers authored by Chiranjeevi Padala

Since Specialization

Citations

This map shows the geographic impact of Chiranjeevi Padala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chiranjeevi Padala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chiranjeevi Padala more than expected).

Fields of papers citing papers by Chiranjeevi Padala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chiranjeevi Padala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chiranjeevi Padala. The network helps show where Chiranjeevi Padala may publish in the future.

Co-authorship network of co-authors of Chiranjeevi Padala

This figure shows the co-authorship network connecting the top 25 collaborators of Chiranjeevi Padala. A scholar is included among the top collaborators of Chiranjeevi Padala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chiranjeevi Padala. Chiranjeevi Padala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biodegradable and biocompatible nonisocyanate polyurethanes synthesized from bio-derived precursors 2024 ·Polymer ·(unknown), (unknown), Konda Reddy Kunduru, Chiranjeevi Padala, Bramanandam Manavathi, Tushar Jana	7
2	In-vitro biomineralization, mechanical properties and drug release efficacy of tantalum containing borophosphate bioactive glasses 2023 ·Journal of Drug Delivery Science and Technology ·S. Patel, (unknown), Bramanandam Manavathi, (unknown), Chiranjeevi Padala	7
3	Structural and in vitro biological properties of strontium substituted bio-waste derived wollastonite for bone regeneration 2023 ·Ceramics International ·Srinath Palakurthy, S. Patel, K. Venugopal Reddy, (unknown), Chiranjeevi Padala, Bramanandam Manavathi, (unknown)	4
4	In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size 2022 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown)	7
5	Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer 2022 ·Cytokine ·Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bramanandam Manavathi, (unknown)	6
6	A reciprocal feedback loop between HIF-1α and HPIP controls phenotypic plasticity in breast cancer cells 2021 ·Cancer Letters ·(unknown), Vasudevarao Penugurti, (unknown), (unknown), Kishore Hari, Mohit Kumar Jolly, (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), Bramanandam Manavathi	14
7	Hematopoietic PBX‐interacting protein is a novel regulator of mammary epithelial cell differentiation 2021 ·FEBS Journal ·(unknown), Chiranjeevi Padala, Anita Kumari, (unknown), Vasudevarao Penugurti, (unknown), Aprotim Mazumder, Vincent Goffin, Bramanandam Manavathi	7
8	HPIP protooncogene differentially regulates metabolic adaptation and cell fate in breast cancer cells under glucose stress via AMPK and RNF2 dependent pathways 2021 ·Cancer Letters ·Vasudevarao Penugurti, (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), Bramanandam Manavathi	18
9	A novel cost-effective approach to fabricate diopside bioceramics: A promising ceramics for orthopedic applications 2021 ·Advanced Powder Technology ·Srinath Palakurthy, P. Abdul Azeem, K. Venugopal Reddy, Chiranjeevi Padala, Bramanandam Manavathi, R. Prasada Rao	28
10	Collagenase-1 (-1607 1G/2G), Gelatinase-A (-1306 C/T), Stromelysin-1 (-1171 5A/6A) functional promoter polymorphisms in risk prediction of type 2 diabetic nephropathy 2018 ·Gene ·(unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Swarnalatha Guditi, (unknown), (unknown)	14
11	Association of CYBA gene (-930 A/G and 242 C/T) polymorphisms with oxidative stress in breast cancer: a case-control study 2018 ·PeerJ ·(unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
12	Polymorphic variants of Caspase genes (8 & 3) in the risk prediction of Coronary Artery Disease 2017 ·Gene ·(unknown), (unknown), (unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown)	7
13	Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer 2017 ·PLoS ONE ·Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Vishnupriya Satti, (unknown)	48
14	MMP 1 circulating levels and promoter polymorphism in risk prediction of coronary artery disease in asymptomatic first degree relatives 2016 ·Gene ·(unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), Altaf Ali, (unknown), (unknown), Pratibha Nallari, (unknown)	10
15	Polymorphisms of extrinsic death receptor apoptotic genes (FAS −670 G>A, FASL −844 T>C) in coronary artery disease 2016 ·APOPTOSIS ·(unknown), (unknown), (unknown), (unknown), Chiranjeevi Padala, Altaf Ali, (unknown), Pratibha Nallari, (unknown)	8
16	Genetic polymorphisms of eNOS (-786T/C, Intron 4b/4a & 894G/T) and its association with asymptomatic first degree relatives of coronary heart disease patients 2016 ·Nitric Oxide ·(unknown), (unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), Altaf Ali, (unknown)	7
17	Evaluation of Hs-CRP Levels and Interleukin 18 (-137G/C) Promoter Polymorphism in Risk Prediction of Coronary Artery Disease in First Degree Relatives 2015 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Made Ratna Saraswati, (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), (unknown)	15
18	Rrp1B gene polymorphism (1307T>C) in metastatic progression of breast cancer 2014 ·Tumor Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Chiranjeevi Padala, (unknown), (unknown), (unknown), Vishnupriya Satti	6
19	Gelatinase B (−1562C/T) polymorphism in tumor progression and invasion of breast cancer 2013 ·Tumor Biology ·Chiranjeevi Padala, (unknown), (unknown), (unknown), (unknown), Made Ratna Saraswati, (unknown), (unknown), (unknown), (unknown), (unknown), S. Vishnupriya, (unknown)	30
20	Interleukin 6(-174G/C) Variant and its Circulating Levels in Coronary Artery Disease Patients and Their First Degree Relatives 2013 ·Inflammation ·(unknown), (unknown), Chiranjeevi Padala, Kishore Kumar, (unknown), (unknown), (unknown), (unknown), (unknown)	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact